It is widely acknowledged that 80% of our immune system resides in our gut. Therefore, healthy microbiota—bio-diverse gut flora comprised of healthy strains of bacteria—may offer a powerful key to preventing disease, including cancer. Turns out, a healthy microbiome may also significantly enhance the treatment outcomes of anticancer agents, most notably novel targeted immunotherapies.